Treatment of Epidermal Growth Factor Receptor Antagonist-Induced Skin Rash: Results of a Survey among German Oncologists

Publisher： Karger

E-ISSN： 2296-5262|33|3|94-98

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.33, Iss.3, 2010-02, pp. : 94-98

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Impact and Management of Skin Toxicity Associated with Anti-Epidermal Growth Factor Receptor Therapy: Survey Results

By  

Oncology, Vol. 72, Iss. 3-4, 2007-12 ,pp. : 152-159

Karger

Access to resources Recommend Favorite

Risk of High-Grade Skin Rash in Cancer Patients Treated with Cetuximab – an Antibody against Epidermal Growth Factor Receptor: Systemic Review and Meta-Analysis

By  

Oncology, Vol. 77, Iss. 2, 2009-07 ,pp. : 124-133

Karger

Access to resources Recommend Favorite

Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment

By  

Current Signal Transduction Therapy, Vol. 7, Iss. 1, 2012-01 ,pp. : 3-13

Bentham Science Publishers

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor mRNA Is Not Increased in Psoriatic Skin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 17, Iss. 2, 1990-02 ,pp. : 104-107

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Epidermal Growth Factor Receptor Inhibitor-Related Skin Toxicity Index (EGFRISTI): A New Tool for Grading and Managing Skin Adverse Reactions to Epidermal Growth Factor Receptor Inhibitors

By  

Oncology, Vol. 87, Iss. 5, 2014-08 ,pp. : 311-319

Karger

Access to resources Recommend Favorite